Addressing the Complexity of Process Validation for Cell and Gene Therapy Products

Addressing the Complexity of Process Validation for Cell and Gene Therapy Products

The manufacturing processes used in the production of gene therapy products are complex, as are the raw materials used during production. Controlling both is critical to ensuring the safety and the efficacy of these products, and process validation is one of the key elements required to successfully deliver them to patients.

Learn how to develop a robust validation package that supports these novel therapies.

Resource Library

Related Sites

Additional Resources